Download full-text PDF

Source

Publication Analysis

Top Keywords

[verapamil ventricular
4
ventricular arrhythmias
4
arrhythmias interference
4
interference ventricular
4
ventricular recovery
4
recovery phase]
4
[verapamil
1
arrhythmias
1
interference
1
ventricular
1

Similar Publications

Introduction: A healthy young woman, age 26 without prior cardiac complications, experienced an out-of-hospital cardiac arrest caused by ventricular fibrillation (VF), which coincided with a fever. Comprehensive diagnostics including echo, CMR, exercise testing, and genetic sequencing, did not identify any potential cause. This led to the diagnosis of idiopathic VF and installment of an implantable cardioverter defibrillator, which six months later appropriately intervened another VF episode under conditions comparable to the first event.

View Article and Find Full Text PDF

Background: Catecholaminergic polymorphic ventricular tachycardia (CPVT) is suspected by clinical characteristics involving fatal arrhythmic events in childhood and adolescence. On the other hand, genetic testing is also important because the mutation site in the specific genes of CPVT is related to the risk of ventricular arrhythmias and gene penetrance.

Case Summary: We present a case of a 15-year-old male with a familial history of CPVT and a history of syncope at the age of 5.

View Article and Find Full Text PDF

Background: Direct oral anticoagulants (DOACs) are preferred for stroke prevention in nonvalvular atrial fibrillation (NVAF); however, warfarin is still used. This study examined why physicians may choose warfarin over DOACs and the associated safety outcomes in patients with NVAF.

Methods: We conducted a new-user, active-comparator cohort study in newly diagnosed patients with NVAF to assess safety outcomes after the introduction of DOACs in Japan.

View Article and Find Full Text PDF

A case report of verapamil toxicity leading to haemodynamic compromise in obstructive hypertrophic cardiomyopathy.

Eur Heart J Case Rep

December 2024

Department of Medicine, Division of Cardiology, University of California, Irvine, 333 City Blvd W, Orange, CA 92868, USA.

Background: Hypertrophic cardiomyopathy (HCM) is an inherited condition characterized by left ventricular (LV) hypertrophy unexplained by increased afterload, often with concomitant outflow tract obstruction. Verapamil is commonly used to treat symptomatic patients. However, its potential for adverse effects should be recognized.

View Article and Find Full Text PDF
Article Synopsis
  • A 10-year-old boy with long QT syndrome type 3 (LQT3) experienced severe episodes of torsade de pointes (TdP) associated with fast ventricular arrhythmias.
  • After replacing his implantable cardioverter-defibrillator, he faced an "electrical storm" that didn't improve even with rapid heart pacing.
  • Treatment with dexmedetomidine and verapamil successfully controlled the TdP, emphasizing the need to address specific rapid arrhythmias in patients with LQT3.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!